Management of differentiated thyroid cancer (Registro nro. 22770)
[ vista simple ]
| 000 -Cabecera | |
|---|---|
| Campo de control interno | 01960nam a2200265 4500 |
| 001 - Número de control | |
| control field | ESSALUD |
| 005 - Fecha y hora de la última transacción | |
| Campo de control | 20260805101217.0 |
| 007 - Tipo material - Descripcion fisica - info general | |
| Tipo material - Descripcion fisica - info general | ta |
| 008 - Elementos de Longitud Fija - Información General | |
| Elementos de Longitud Fija - Información | t pe ||||| |||| 00| 0 spa d |
| 040 ## - Origen de la Catalogación | |
| Origen de la Catalogación | BMG |
| 041 ## - Idioma | |
| Idioma | eng |
| 100 ## - Autor | |
| Autor | Hegedüs, Laszlo |
| 9 (RLIN) | 53915 |
| 245 ## - Titulo | |
| Titulo | Management of differentiated thyroid cancer |
| 300 ## - Páginas | |
| Paginación | páginas: 2340-2355 |
| 520 ## - Resumen | |
| Resumen | Modern risk-adapted management of thyroid cancer involves risk stratification as an active, dynamic process that begins with the detection of a thyroid nodule and continues throughout the clinical course of diagnosis, active surveillance or treatment, and follow-up. Rooted in clinicopathological staging, which can be further refined with the molecular risk characterization of the tumor, initial management plans are developed and modified over time on the basis of the natural history of the disease and the response to therapy. We present a clinical framework for therapeutic decision making that can be used to compare, contrast, and illustrate the relative risks, benefits, and patient preferences that are integral to the development of a personalized management plan. We examine examples of therapeutic decision making in active surveillance of low-risk papillary thyroid cancer, minimalist therapeutic management options for low- and intermediate-risk thyroid cancer, and systemic therapies for advanced thyroid cancer, showing how the therapeutic decision-making framework can be used to achieve informed consensus and management recommendations. |
| 650 ## - Temas - Descriptores | |
| Temas - Descriptores | MEDICINA DEL ADOLESCENTE |
| 9 (RLIN) | 5533 |
| 650 ## - Temas - Descriptores | |
| Temas - Descriptores | CANCER INFANTIL |
| 9 (RLIN) | 53916 |
| 650 ## - Temas - Descriptores | |
| Temas - Descriptores | HEMATOLOGÍA |
| 9 (RLIN) | 7422 |
| 650 ## - Temas - Descriptores | |
| Temas - Descriptores | ONCOLOGÍA |
| 9 (RLIN) | 12240 |
| 650 ## - Temas - Descriptores | |
| Temas - Descriptores | HEMATOLOGÍA |
| 9 (RLIN) | 7422 |
| 700 ## - Autor Personal | |
| Autor Personal | Wirth, Lori J. |
| 9 (RLIN) | 53917 |
| 700 ## - Autor Personal | |
| Autor Personal | Tuttle , R. Michael |
| 9 (RLIN) | 53918 |
| 773 0# - Revista (Relacion con el numero) | |
| Host Biblionumber | 22717 |
| Host Itemnumber | 22640 |
| Ciudad, Editorial | Massachusetts NEJM Group |
| Codigo barras item/ejemplar | NEJM007 |
| Titulo de la Revista | The New England Journal of Medicine |
| Número de control de registro | ESSALUD |
| ISSN | 0028-4793 |
| 942 ## - Elementos de Koha | |
| Tipo de Documento | Artículos |
| Fecha procesamiento | 2026-08-03 |
| Catalogador | SQB |
No hay ítems disponibles.